A multi-center clinical trial evaluating the safety and effectiveness of two different candidate microbicides, BufferGel® and PRO 2000, in 3,100 sexually active HIV-negative women at seven sites in Africa and the United States. Results have been reported. (See news release below.)
New findings reported by Microbicide Trials Network at International HIV Prevention Meeting
17-April-2012
9-February-2009
9-February-2009
9-February-2009
See Also
Microbicide Trials Network statement on the results of MDP 301
14-December-2009
Trial finds microbicide promising as HIV prevention method for women
9-February-2009